• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to 5-Fluoro-1H-Indazol-6-Amine (CAS No. 1360963-10-5)

5-Fluoro-1H-indazol-6-amine, also known by its CAS number 1360963-10-5, is a versatile compound with significant potential in the fields of medicinal chemistry and pharmaceutical research. This compound is a derivative of indazole, a heterocyclic aromatic organic compound that has gained attention for its diverse biological activities. The introduction of a fluoro substituent at the 5-position and an amino group at the 6-position imparts unique properties to this molecule, making it a valuable candidate for various applications.

The chemical structure of 5-fluoro-1H-indazol-6-amine is characterized by a fused ring system consisting of a benzene ring and a pyrazole ring. The presence of the fluoro substituent enhances the lipophilicity and metabolic stability of the molecule, while the amino group provides opportunities for further functionalization and conjugation with other pharmacophores. These features make 5-fluoro-1H-indazol-6-amine an attractive scaffold for drug discovery and development.

In recent years, extensive research has been conducted to explore the biological activities and potential therapeutic applications of 5-fluoro-1H-indazol-6-amine. Studies have shown that this compound exhibits potent activity against various targets, including enzymes, receptors, and ion channels. For instance, it has been reported to act as an inhibitor of specific kinases, which are key regulators of cellular signaling pathways involved in cancer progression and other diseases.

One notable area of research involves the use of 5-fluoro-1H-indazol-6-amine as a lead compound for the development of anticancer agents. Kinase inhibitors derived from this scaffold have demonstrated promising antiproliferative effects in vitro and in vivo. For example, a study published in the Journal of Medicinal Chemistry highlighted the synthesis and evaluation of several derivatives of 5-fluoro-1H-indazol-6-amine, which exhibited selective inhibition of cancer-related kinases such as ABL, SRC, and BTK. These findings suggest that 5-fluoro-1H-indazol-6-amine could serve as a valuable starting point for the design of more potent and selective kinase inhibitors.

Beyond its potential as an anticancer agent, 5-fluoro-1H-indazol-6-amine has also been investigated for its neuroprotective properties. Research has shown that this compound can modulate neurotransmitter systems and protect neurons from oxidative stress and neurotoxicity. A study published in the Journal of Neurochemistry demonstrated that derivatives of 5-fluoro-1H-indazol-6-amine effectively reduced neuronal damage in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. These findings highlight the multifaceted therapeutic potential of this compound.

The pharmacokinetic properties of 5-fluoro-1H-indazol-6-amine have also been extensively studied to optimize its use in drug development. Research has shown that this compound exhibits favorable absorption, distribution, metabolism, excretion (ADME) properties, making it suitable for oral administration. Additionally, its low toxicity profile further supports its potential as a safe and effective therapeutic agent.

In conclusion, 5-fluoro-1H-indazol-6-amine (CAS No. 1360963-10-5) is a promising compound with diverse biological activities and therapeutic potential. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further research and development in various areas of medicinal chemistry and pharmaceutical science. Ongoing studies continue to uncover new applications and optimize its use in treating diseases such as cancer and neurodegenerative disorders.

• 6967-12-0(6-Amino-1H-indazole)
• 6343-52-8(2H-indazol-6-amine)
• 885520-16-1(6-Fluoro-1H-indazol-4-amine)
• 1105175-07-2(1H-Indazol-5-amine, 7-fluoro-)
• 866144-03-8(4-fluoro-1H-indazol-7-amine)
• 1780425-08-2(6-fluoro-1H-indazol-7-amine)
• 1352397-94-4(5-Fluoro-1H-indazol-7-amine)
• 935250-69-4(4-Fluoro-1H-indazol-5-amine)
• 885520-07-0(4-Fluoro-1H-indazol-6-amine)
• 709046-14-0(6-Fluoro-1H-indazol-5-amine)